166 related articles for article (PubMed ID: 2466370)
1. Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51.
Portetelle D; Couez D; Bruck C; Kettmann R; Mammerickx M; Van der Maaten M; Brasseur R; Burny A
Virology; 1989 Mar; 169(1):27-33. PubMed ID: 2466370
[TBL] [Abstract][Full Text] [Related]
2. Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability.
Bruck C; Rensonnet N; Portetelle D; Cleuter Y; Mammerickx M; Burny A; Mamoun R; Guillemain B; van der Maaten MJ; Ghysdael J
Virology; 1984 Jul; 136(1):20-31. PubMed ID: 6204449
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and immunological characterization of the bovine leukemia virus (BLV) envelope glycoprotein (gp51) produced in Saccharomyces cerevisiae.
Legrain M; Portetelle D; Dumont J; Burny A; Hilger F
Gene; 1989 Jul; 79(2):227-37. PubMed ID: 2551774
[TBL] [Abstract][Full Text] [Related]
4. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
[TBL] [Abstract][Full Text] [Related]
5. Expression of the bovine leukemia virus envelope glycoprotein (gp51) by recombinant baculovirus and its use in an enzyme-linked immunosorbent assay.
De Giuseppe A; Feliziani F; Rutili D; De Mia GM
Clin Diagn Lab Immunol; 2004 Jan; 11(1):147-51. PubMed ID: 14715562
[TBL] [Abstract][Full Text] [Related]
6. Development of a specific serological test and an efficient subunit vaccine to control bovine leukemia virus infection.
Portetelle D; Burny A; Desmettre P; Mammerickx M; Paoletti E; Zavada J
Dev Biol Stand; 1990; 72():81-90. PubMed ID: 1704325
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51.
Bruck C; Mathot S; Portetelle D; Berte C; Franssen JD; Herion P; Burny A
Virology; 1982 Oct; 122(2):342-52. PubMed ID: 6183819
[No Abstract] [Full Text] [Related]
8. Elicitation of bovine antibody to BLV-gp51 by BLV-vaccination.
Maruyama K; Fukushima T; Mochizuki S; Abe H; Onuma M; Hasegawa A; Misawa M
Leukemia; 1988 Dec; 2(12 Suppl):216S-222S. PubMed ID: 2848999
[TBL] [Abstract][Full Text] [Related]
9. Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.
Ban J; Czene S; Altaner C; Callebaut I; Krchnak V; Merza M; Burny A; Kettmann R; Portetelle D
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2457-61. PubMed ID: 1383413
[TBL] [Abstract][Full Text] [Related]
10. Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51.
Portetelle D; Mammerickx M; Burny A
J Virol Methods; 1989 Feb; 23(2):211-22. PubMed ID: 2542354
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.
Bai L; Otsuki H; Sato H; Kohara J; Isogai E; Takeshima SN; Aida Y
Retrovirology; 2015 Dec; 12():106. PubMed ID: 26715158
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel overlapping sequential E epitope (E') on the bovine leukaemia virus SU glycoprotein and analysis of immunological data.
Forti K; Rizzo G; Cagiola M; Ferrante G; Marini C; Feliziani F; Pezzotti G; De Giuseppe A
Vet Microbiol; 2014 Aug; 172(1-2):157-67. PubMed ID: 24916842
[TBL] [Abstract][Full Text] [Related]
13. Epitopes of bovine leukemia virus glycoprotein gp51 recognized by sera of infected cattle and sheep.
Bruck C; Portetelle D; Mammerickx M; Mathot S; Burny A
Leuk Res; 1984; 8(3):315-21. PubMed ID: 6205222
[TBL] [Abstract][Full Text] [Related]
14. Computational analysis of envelope glycoproteins from diverse geographical isolates of bovine leukemia virus identifies highly conserved peptide motifs.
Pluta A; Albritton LM; Rola-Łuszczak M; Kuźmak J
Retrovirology; 2018 Jan; 15(1):2. PubMed ID: 29310678
[TBL] [Abstract][Full Text] [Related]
15. Immunoaffinity purification of two major proteins of bovine leukemia virus (gp51 and p24) and their use for discrimination between vaccinated and infected animals.
Merza M; Sundquist B; Söber J; Morein B
J Virol Methods; 1991 Aug; 33(3):345-53. PubMed ID: 1723735
[TBL] [Abstract][Full Text] [Related]
16. Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1.
Orlik O; Ban J; Hlavaty J; Altaner C; Kettmann R; Portetelle D; Splitter GA
J Virol; 1997 Apr; 71(4):3263-7. PubMed ID: 9060692
[TBL] [Abstract][Full Text] [Related]
17. Expression of env sequences of the bovine leukemia virus (BLV) in the yeast Saccharomyces cerevisiae.
Brantl S; Eldarov MA; Rössler H; Drescher B; Lang H; Rosenthal S; Skryabin KG
Yeast; 1988 Mar; 4(1):47-59. PubMed ID: 2849260
[TBL] [Abstract][Full Text] [Related]
18. [Exposure of the major immunodominant epitope of the gp51 envelope protein of bovine leukosis virus on the surface of the hepatitis B core antigen capsid].
Ul'rikh R; Borisova GP; Siakkou Kh; Plattser K; Ose VP; Berzin' IG; Dreĭlinia DE; Pushko PM; Tsibinogin VV; Pumpen PP
Mol Biol (Mosk); 1991; 25(2):368-74. PubMed ID: 1715509
[TBL] [Abstract][Full Text] [Related]
19. Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins.
Mamoun RZ; Morisson M; Rebeyrotte N; Busetta B; Couez D; Kettmann R; Hospital M; Guillemain B
J Virol; 1990 Sep; 64(9):4180-8. PubMed ID: 1696635
[TBL] [Abstract][Full Text] [Related]
20. Identification of an immunodominant region on the isolated bovine leukaemia virus (BLV) major envelope protein gp51 by monoclonal antibodies presumably not exposed during natural BLV infection.
Platzer C; Siakkou H; Sober J; Kopp J; Scheve E; Rosenthal S
Acta Virol; 1990 May; 34(3):246-55. PubMed ID: 1980398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
